![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current EYEGW market cap is 192.23k. The company's latest EPS is USD -1.6966 and P/E is -2.20.
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 16.01M |
Operating Income | -1.92M | -2.63M | -5.92M | -2.12M | 13.22M |
Net Income | -1.87M | -2.61M | -6.29M | -2.27M | 13.45M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 2.69M | 12k | 0 | 0 | 0 |
Operating Income | -7.11M | -8.21M | -16.94M | -12.31M | -12.59M |
Net Income | -7.1M | -8.09M | -16.4M | -13.58M | -13.05M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 16.53M | 19.89M | 15.9M | 13.71M | 42.44M |
Total Liabilities | 6.37M | 6.24M | 7.79M | 7.6M | 7.54M |
Total Equity | 10.16M | 13.64M | 8.1M | 6.11M | 34.9M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 10.11M | 15.16M | 18.06M | 18.68M | 13.71M |
Total Liabilities | 3.49M | 8.16M | 8.83M | 7.27M | 7.6M |
Total Equity | 6.62M | 7M | 9.23M | 11.41M | 6.11M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -3.07M | -4.46M | -6.98M | -9.56M | 13.63M |
Investing | N/A | N/A | N/A | N/A | N/A |
Financing | 513k | 6.45M | 6.45M | 5.97M | 15.25M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -8.15M | -7.32M | -10.89M | -10.43M | -9.56M |
Investing | N/A | -244k | -157k | 6k | N/A |
Financing | 3.92M | 5M | 17.8M | 8.62M | 5.97M |
Market Cap | 192.23k |
Price to Earnings Ratio | -2.20 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 11.68 |
Price to Book Ratio | 4.69 |
Dividend Yield | - |
Shares Outstanding | 7.69M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0.49 (98%) |
Company Name | Eyegate Pharmaceuticals Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://kiorapharma.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions